Botulinum toxin type A inhibits the formation of hypertrophic scar through the JAK2/STAT3 pathway
Biomolecules and Biomedicine · 10.08.2024 · 25 (1) · 249-258
DOI: 10.17305/bb.2024.10906 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules and Biomedicine, online erschienen am 10.08.2024. Verfasst von Yan Fan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Shanxi Medical University, Shanxi, China; Department of Burns and Plastic Surgery, Children's Hospital of Shanxi (Women He…. Hauptthemen laut MEDLINE: Janus Kinase 2, STAT3 Transcription Factor, Cicatrix, Hypertrophic, Botulinum Toxins, Type A. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hypertrophic scar (HS) is a fibrous proliferative disorder that occurs in the dermis after skin injury. Studies have confirmed that Botulinum toxin type A (BTA) is effective in scar prevention and treatment. However, the specific mechanism remains uncertain. Hypertrophic scar fibroblasts (HSFs) and normal skin fibroblasts (NSFs) from the skin tissues of HS patients were isolated and cultured. Western blot analysis was conducted to measure the expression of JAK2/STAT3 pathway-related proteins. HSFs were treated with the JAK2 inhibitor (AG490) or agonist (C-A1). The CCK-8 assay, EdU staining, scratch-wound assay and transwell assay were used to examine the biological properties of HSFs. Western blot, immunofluorescence, and Sirius red staining were used to assess the fibrosis of HSFs. Additionally, a mouse full-thickness wound model was constructed to investigate the role of BTA in wound healing. The results showed that the JAK2 and STAT3 phosphorylation levels were markedly increased in HS tissues and HSFs. AG490 treatment reduced cell viability, proliferation and migration capacity, and inhibited the fibrosis of HSFs, whereas C-A1 treatment had the opposite effect. BTA treatment inhibited the JAK2/STAT3 pathway. BTA reduced cell viability, proliferation and migration ability, and inhibited the fibrosis of HSFs, while C-A1 intervention weakened the impact of BTA. Meanwhile, BTA promoted wound healing and reduced collagen deposition in vivo. In conclusion, BTA inhibited the JAK2/STAT3 pathway, which in turn hindered the proliferation, migration and fibrosis of HSFs, and promoted wound healing in mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Paediatrics, Shanxi Medical University, Shanxi, China; Department of Burns and Plastic Surgery, Children's Hospital of Shanxi (Women Health Center of Shanxi), Shanxi, China.
- Department of Burns and Plastic Surgery, Children's Hospital of Shanxi (Women Health Center of Shanxi), Shanxi, China.
- Department of Orthopedics, Children's Hospital of Shanxi (Women Health Center of Shanxi), Shanxi, China.
- Department of General Surgery, Children's Hospital Affiliated to Shanxi Medical University, Shanxi, China.
Zitieren
APA
Fan, Y., Guo, X., Tian, Y., Li, J., & Xi, H. (2024). Botulinum toxin type A inhibits the formation of hypertrophic scar through the JAK2/STAT3 pathway. Biomolecules and Biomedicine, 25(1), 249-258. https://doi.org/10.17305/bb.2024.10906
Vancouver
Fan Y, Guo X, Tian Y, Li J, Xi H. Botulinum toxin type A inhibits the formation of hypertrophic scar through the JAK2/STAT3 pathway. Biomolecules and Biomedicine. 2024;25(1):249-258. doi:10.17305/bb.2024.10906
BibTeX
@article{Fan2024,
author = {Fan, Yan and Guo, Xuesong and Tian, Yu and Li, Jie and Xi, Hongwei},
title = {Botulinum toxin type A inhibits the formation of hypertrophic scar through the JAK2/STAT3 pathway},
journal = {Biomolecules and Biomedicine},
year = {2024},
volume = {25},
number = {1},
pages = {249--258},
doi = {10.17305/bb.2024.10906}
}
EUVIMED